Endoscopic sleeve gastroplasty: is it time to prioritize minimally invasive interventions for the management of metabolic syndrome?
作者信息
Picón-Jaimes Yelson A, Solano-Ninco María F, Rincón-Lozano Zaira Y, Ortiz-Rodríguez Marlly G, Uribe-Botero Cesar A, Narvaez-Rojas Alexis R
机构信息
Fac Ciències Salut Blanquerna, Univ Ramon Llul, Barcelona, Spain.
School of Medicine, Fundación Universitaria de Ciencias de la Salud.
出版信息
Ann Med Surg (Lond). 2023 Feb 7;85(2):331-332. doi: 10.1097/MS9.0000000000000167. eCollection 2023 Feb.
Abstract
摘要
相似文献
1
Endoscopic sleeve gastroplasty: is it time to prioritize minimally invasive interventions for the management of metabolic syndrome?内镜袖状胃成形术：是时候将微创干预作为代谢综合征管理的优先选择了吗？
Ann Med Surg (Lond). 2023 Feb 7;85(2):331-332. doi: 10.1097/MS9.0000000000000167. eCollection 2023 Feb.
2
Initial experience with endoscopic sleeve gastroplasty in Poland.波兰内镜下袖状胃成形术的初步经验。
Pol Przegl Chir. 2018 Apr 30;90(2):16-22. doi: 10.5604/01.3001.0011.7488.
3
Initial experience with endoscopic sleeve gastroplasty in Poland.波兰内镜下袖状胃成形术的初步经验。
Pol Przegl Chir. 2018 Jun 13;90(4):35-40. doi: 10.5604/01.3001.0011.8183.
4
Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study).内镜袖状胃成形术与腹腔镜袖状胃切除术治疗非酒精性脂肪性肝炎（NASH）肥胖患者的疗效和安全性：一项随机对照试验（TESLA-NASH 研究）的研究方案。
Trials. 2021 Oct 30;22(1):756. doi: 10.1186/s13063-021-05695-7.
5
Efficacy and safety of endoscopic sleeve gastroplasty for obesity patients: a meta-analysis.内镜袖状胃成形术治疗肥胖症患者的疗效和安全性：一项荟萃分析。
Surg Endosc. 2020 Mar;34(3):1253-1260. doi: 10.1007/s00464-019-06889-6. Epub 2019 Jun 24.
6
Systematic Review and Meta-Analysis of Endoscopic Sleeve Gastroplasty with Comparison to Laparoscopic Sleeve Gastrectomy.内镜袖状胃成形术与腹腔镜袖状胃切除术的系统评价和荟萃分析。
Obes Surg. 2020 Jul;30(7):2754-2762. doi: 10.1007/s11695-020-04591-4.
7
Matched Endoscopic Sleeve Gastroplasty and Laparoscopic Sleeve Gastrectomy Cases: Formative Cohort Study.配对的内镜袖状胃成形术和腹腔镜袖状胃切除术病例：前瞻性队列研究。
JMIR Form Res. 2022 Nov 24;6(11):e29713. doi: 10.2196/29713.
8
Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity.内镜下袖状胃成形术——非酒精性脂肪性肝病和肥胖症的微创治疗方法
Indian J Gastroenterol. 2021 Dec;40(6):572-579. doi: 10.1007/s12664-021-01202-7. Epub 2021 Dec 16.
9
Laparoscopic Sleeve Gastrectomy After Endoscopic Sleeve Gastroplasty: Technical Aspects and Short-Term Outcomes.内镜下袖状胃成形术后腹腔镜袖状胃切除术：技术要点和短期疗效。
Obes Surg. 2019 Nov;29(11):3547-3552. doi: 10.1007/s11695-019-04024-x.
10
Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: First Indian experience.内镜袖状胃成形术是一种有效且安全的微创治疗肥胖症的方法：印度的首次临床经验。
Dig Endosc. 2020 May;32(4):541-546. doi: 10.1111/den.13508. Epub 2019 Nov 1.
本文引用的文献
1
Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial.内镜袖状胃切除术治疗 1 型和 2 型肥胖症（MERIT）：一项前瞻性、多中心、随机试验。
Lancet. 2022 Aug 6;400(10350):441-451. doi: 10.1016/S0140-6736(22)01280-6. Epub 2022 Jul 28.
2
Training the trainers: The fundamental basis for guaranteeing the evolution of academic surgery in third world countries.培训培训者：保障第三世界国家外科学术发展的根本基础。
Int J Surg. 2022 Mar;99:106257. doi: 10.1016/j.ijsu.2022.106257. Epub 2022 Feb 15.
3
Efficacy and safety of endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy with 12+ months of adjuvant multidisciplinary support.内镜袖状胃成形术和腹腔镜袖状胃切除术在接受12个月以上辅助多学科支持下的疗效与安全性。
BMC Prim Care. 2022 Feb 5;23(1):26. doi: 10.1186/s12875-022-01629-7.
4
Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis.2020 年全球、区域和国家儿童和青少年代谢综合征负担估计：系统评价和建模分析。
Lancet Child Adolesc Health. 2022 Mar;6(3):158-170. doi: 10.1016/S2352-4642(21)00374-6. Epub 2022 Jan 17.
5
Global outcomes, surgical teams and COVID-19 pandemic: Will the same objectives of global surgery persist?全球手术成果、手术团队与新冠疫情：全球手术的相同目标还会持续存在吗？
Ann Med Surg (Lond). 2021 Nov;71:103002. doi: 10.1016/j.amsu.2021.103002. Epub 2021 Oct 30.
6
Molecular and computational research in low- and middle-income countries: Development is close at hand.低收入和中等收入国家的分子与计算研究：发展近在咫尺。
J Taibah Univ Med Sci. 2021 Dec;16(6):948-949. doi: 10.1016/j.jtumed.2021.06.010. Epub 2021 Aug 5.
7
The need to develop specialized surgical centers: the evidence that surgical diseases cannot wait.发展专业外科中心的必要性：外科疾病不能等待的证据。
Int J Surg. 2021 Aug;92:106036. doi: 10.1016/j.ijsu.2021.106036. Epub 2021 Jul 30.
8
Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults.57个低收入和中等收入国家的体重指数与糖尿病风险：一项基于685616名成年人全国代表性个体水平数据的横断面研究
Lancet. 2021 Jul 17;398(10296):238-248. doi: 10.1016/S0140-6736(21)00844-8.
9
Endoscopic Sleeve Gastroplasty (ESG) for High-Risk Patients, High Body Mass Index (> 50 kg/m) Patients, and Contraindication to Abdominal Surgery.内镜袖状胃切除术（ESG）用于高危患者、高身体质量指数（>50kg/m）患者和腹部手术禁忌证。
Obes Surg. 2021 Aug;31(8):3400-3409. doi: 10.1007/s11695-021-05446-2. Epub 2021 Apr 27.
10
Efficacy of Endoscopic Interventions for the Management of Obesity: a Meta-analysis to Compare Endoscopic Sleeve Gastroplasty, AspireAssist, and Primary Obesity Surgery Endolumenal.内镜干预治疗肥胖症的疗效：比较内镜袖状胃切除术、AspireAssist 和原发性肥胖症内镜手术的荟萃分析。
Obes Surg. 2019 Jul;29(7):2287-2298. doi: 10.1007/s11695-019-03865-w.
Zotero 插件